The Scientist

» biotechnology

Most Recent

image: DARPA Supports Brain Treatment

DARPA Supports Brain Treatment

By | October 28, 2013

Brain-implant technologies just got a vote of government confidence, as the Defense Advanced Research Projects Agency announces an investment of $70 million over five years.

1 Comment

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Venter’s New Digs

Venter’s New Digs

By | October 9, 2013

Genomics pioneer Craig Venter is building a new campus for his non-profit research institute right next to his alma mater in San Diego.

0 Comments

image: Building 3-D Microbial Communities

Building 3-D Microbial Communities

By | October 7, 2013

Researchers apply a 3-D printing technique to structure populations of bacteria in a three-dimensional environment.

0 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Remaking a Classic

Remaking a Classic

By | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

image: Week in Review: August 26–30

Week in Review: August 26–30

By | August 30, 2013

New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

image: Opinion: Racing Toward Invention

Opinion: Racing Toward Invention

By | July 23, 2013

A newly instated patent law discriminates against academics and small biotechs.

6 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham